A Six-Week, Parallel, Randomized, Double-Blind Study Comparing the Efficacy and Safety of the 0.5% Timolol/2.0% MK-507 Combination B.I.D. to the Concomitant Administration of 0.5% Timolol B.I.D. and 2.0% MK-507 B.I.D.

Chen Y.-F.CHANG-HAO YANGHung P.T.2022-07-142022-07-1420031080-7683https://www.scopus.com/inward/record.uri?eid=2-s2.0-0142213556&doi=10.1089%2f108076803322472980&partnerID=40&md5=cdb377f044c7b56cd090917c5bdd1018https://scholars.lib.ntu.edu.tw/handle/123456789/615190A Six-Week, Parallel, Randomized, Double-Blind Study Comparing the Efficacy and Safety of the 0.5% Timolol/2.0% MK-507 Combination B.I.D. to the Concomitant Administration of 0.5% Timolol B.I.D. and 2.0% MK-507 B.I.D.journal article10.1089/108076803322472980145831342-s2.0-0142213556